Cala Health nabs $50 mln Series C
Burlingame, California-based Cala Health, Inc, a bioelectronic medicine company, has raised $50 million in Series C financing. The investors included Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, Johnson & Johnson Innovation – JJDC, Inc, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital and GV.
21 May 2019•1 min read
